The legalization of cannabis in Canada nearly four years ago has led to continued growth throughout the value chain. A report released just this past summer titled Cannabis in North America: Ease of Access and Format Diversity Drive Adult Use predicts value sales are expected to grow by 19% by year’s end and even double by 2025.
In turn, Health Canada is continuing to focus on enforcing regulations that maintain both the quality and safety of the many recreational and medicinal products being made available to the public.
This is placing added pressure on manufacturers, growers, and producers of everything from dried cannabis flowers, extracts, and concentrates to vape oils, edibles, topicals and more. It’s also where guidelines such as those detailed by Health Canada and the International Council for Harmonisation (ICH) are becoming more standard in this industry.







